These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28693755)

  • 1. Unraveling interrelationships among psychopathology symptoms, cognitive domains and insight dimensions in chronic schizophrenia.
    Xavier RM; Pan W; Dungan JR; Keefe RSE; Vorderstrasse A
    Schizophr Res; 2018 Mar; 193():83-90. PubMed ID: 28693755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial.
    Stroup S; Appelbaum P; Swartz M; Patel M; Davis S; Jeste D; Kim S; Keefe R; Manschreck T; McEvoy J; Lieberman J
    Schizophr Res; 2005 Dec; 80(1):1-8. PubMed ID: 16182516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlating cognitive functions to symptom domains and insight in Egyptian patients with schizophrenia.
    Khalil AH; El-Meguid MA; Bastawy M; Rabei S; Ali R; Abd Elmoneam MHE
    Int J Soc Psychiatry; 2020 May; 66(3):240-248. PubMed ID: 31928181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study.
    Wobrock T; Falkai P; Schneider-Axmann T; Hasan A; Galderisi S; Davidson M; Kahn RS; Derks EM; Boter H; Rybakowski JK; Libiger J; Dollfus S; López-Ibor JJ; Peuskens J; Hranov LG; Gaebel W; Fleischhacker WW;
    Schizophr Res; 2013 Jun; 147(1):132-139. PubMed ID: 23537477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight in inpatients with schizophrenia: relationship to symptoms and neuropsychological functioning.
    Zhou Y; Rosenheck R; Mohamed S; Zhang J; Chang Q; Ou Y; Sun B; Ning Y; He H
    Schizophr Res; 2015 Feb; 161(2-3):376-81. PubMed ID: 25533592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognition, insight into illness and subjective quality-of-life in schizophrenia: what is their relationship?
    Kurtz MM; Tolman A
    Schizophr Res; 2011 Apr; 127(1-3):157-62. PubMed ID: 21211943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are negative symptoms really related to cognition in schizophrenia?
    Bagney A; Dompablo M; Santabárbara J; Moreno-Ortega M; Lobo A; Jimenez-Arriero MA; Palomo T; Rodriguez-Jimenez R
    Psychiatry Res; 2015 Dec; 230(2):377-82. PubMed ID: 26454405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations.
    Dominguez Mde G; Viechtbauer W; Simons CJ; van Os J; Krabbendam L
    Psychol Bull; 2009 Jan; 135(1):157-71. PubMed ID: 19210058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and cognitive correlates of insight in first-episode schizophrenia.
    Chan SK; Chan KK; Lam MM; Chiu CP; Hui CL; Wong GH; Chang WC; Chen EY
    Schizophr Res; 2012 Mar; 135(1-3):40-5. PubMed ID: 22245186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of insight and insight change in schizophrenia.
    Carroll A; Fattah S; Clyde Z; Coffey I; Owens DG; Johnstone EC
    Schizophr Res; 1999 Feb; 35(3):247-53. PubMed ID: 10093870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of cognition and psychopathology to functional impairment in schizophrenia.
    Mohamed S; Rosenheck R; Swartz M; Stroup S; Lieberman JA; Keefe RS
    Am J Psychiatry; 2008 Aug; 165(8):978-87. PubMed ID: 18450928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of illness severity, cognition, and estimated antipsychotic dopamine receptor occupancy on insight into the illness in schizophrenia: An analysis of clinical antipsychotic trials of intervention effectiveness (CATIE) data.
    Ozzoude M; Nakajima S; Plitman E; Chung JK; Kim J; Iwata Y; Caravaggio F; Takeuchi H; Uchida H; Graff-Guerrero A; Gerretsen P
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():207-213. PubMed ID: 30172739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between insight and symptoms in schizophrenia.
    Sevy S; Nathanson K; Visweswaraiah H; Amador X
    Compr Psychiatry; 2004; 45(1):16-9. PubMed ID: 14671732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological correlates of cognitive insight in schizophrenia.
    Orfei MD; Spoletini I; Banfi G; Caltagirone C; Spalletta G
    Psychiatry Res; 2010 Jun; 178(1):51-6. PubMed ID: 20452049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between insight dimensions and cognitive functions in patients with deficit and nondeficit schizophrenia.
    Pegoraro LFL; Dantas CR; Banzato CEM; Fuentes D
    Schizophr Res; 2013 Jun; 147(1):91-94. PubMed ID: 23535076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of neurocognitive impairment with diminished expression and apathy in schizophrenia.
    Hartmann-Riemer MN; Hager OM; Kirschner M; Bischof M; Kluge A; Seifritz E; Kaiser S
    Schizophr Res; 2015 Dec; 169(1-3):427-432. PubMed ID: 26526750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor.
    Lane HY; Lin CH; Green MF; Hellemann G; Huang CC; Chen PW; Tun R; Chang YC; Tsai GE
    JAMA Psychiatry; 2013 Dec; 70(12):1267-75. PubMed ID: 24089054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between verbal memory, processing speed, negative symptoms and functional capacity in schizophrenia.
    McDowd J; Tang TC; Tsai PC; Wang SY; Su CY
    Psychiatry Res; 2011 May; 187(3):329-34. PubMed ID: 21320727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hopelessness, neurocognitive function, and insight in schizophrenia: relationship to suicidal behavior.
    Kim CH; Jayathilake K; Meltzer HY
    Schizophr Res; 2003 Mar; 60(1):71-80. PubMed ID: 12505140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pioglitazone on metabolic abnormalities, psychopathology, and cognitive function in schizophrenic patients treated with antipsychotic medication: a randomized double-blind study.
    Smith RC; Jin H; Li C; Bark N; Shekhar A; Dwivedi S; Mortiere C; Lohr J; Hu Q; Davis JM
    Schizophr Res; 2013 Jan; 143(1):18-24. PubMed ID: 23200554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.